Gene: TDO2
Official Full Name: tryptophan 2,3-dioxygenaseprovided by HGNC
Gene Summary: This gene encodes a heme enzyme that plays a critical role in tryptophan metabolism by catalyzing the first and rate-limiting step of the kynurenine pathway. Increased activity of the encoded protein and subsequent kynurenine production may also play a role in cancer through the suppression of antitumor immune responses, and single nucleotide polymorphisms in this gene may be associated with autism. [provided by RefSeq, Feb 2012]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO04889 | TDO2 Knockout cell line (A549) | Human | TDO2 | 1:3~1:4 | Negative | Online Inquiry |
TDO2 Gene Knockout Cell Lines are engineered cellular models that have undergone targeted disruption of the TDO2 gene, which encodes the enzyme tryptophan 2,3-dioxygenase. This enzyme plays a crucial role in the kynurenine pathway, regulating not only tryptophan metabolism but also influencing immune response and neurodevelopmental processes. By creating TDO2-null variants, researchers can study the gene's function and its implications in various biological contexts, such as cancer, neurodegenerative diseases, and metabolic disorders.
The key mechanism of TDO2 knockout cell lines lies in their ability to provide a controlled environment for examining the consequences of TDO2 deficiency. By inhibiting the production of kynurenines, these cell lines help elucidate the complex pathways involved in cellular signaling and metabolic homeostasis. As such, they serve as invaluable tools for exploring how disrupted tryptophan metabolism contributes to disease pathology.
In terms of scientific importance, TDO2 gene knockout models find applications in both basic research and clinical settings. They facilitate the exploration of therapeutic strategies that target tryptophan metabolism, potentially leading to novel interventions for cancer immunotherapy or neurodegenerative conditions associated with altered kynurenine levels. Additionally, these cell lines can aid the understanding of immune modulation and response mechanisms during drug development.
One of the primary advantages of our TDO2 Gene Knockout Cell Lines is their highly validated genetic modification, ensuring consistent and reproducible results for experimental use. Unlike alternative models, these cell lines are designed with stringent quality controls, making them reliable for rigorous research applications. Furthermore, our product is compatible with various assay systems, allowing for flexible integration into existing experimental workflows.
For researchers, clinicians, and pharmaceutical professionals seeking to delve into the impact of tryptophan metabolism on health and disease, TDO2 Gene Knockout Cell Lines provide an essential resource. Our company is committed to advancing scientific endeavors through superior biological materials, enabling the discovery and development of innovative solutions in life sciences.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.